# FLUARIX 2026/2027

NDC: 58160-725
Generic name: influenza virus vaccine
Labeler / Manufacturer: GlaxoSmithKline Biologicals SA
Product type: VACCINE
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAMUSCULAR
Marketing started: 20260701
Marketing ended: 20270630
FDA application: BLA125127

## Active ingredients

- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL
- INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58160-725"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58160-725